array(3) { ["company_details"]=> array(13) { ["name"]=> string(25) "Gsk Consumer Health, Inc." ["slug"]=> string(32) "4abba-us-gsk-consumer-health-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/8434ac9a-9bf2-4877-a3a0-a4039c237204" ["description"]=> string(518) "GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company." ["address_street"]=> string(28) "184 Liberty Corner Rd Ste 78" ["address_place"]=> string(6) "Warren" ["address_region"]=> string(10) "New Jersey" ["founding_date"]=> string(10) "1994-02-28" ["website_domain"]=> string(7) "gsk.com" ["website_url"]=> string(19) "https://www.gsk.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(300) ["article_count"]=> int(592) } ["articles"]=> array(7) { [0]=> array(7) { ["title_en"]=> string(63) "Finding strategies to overcome brain diseases based on big data" ["snippet_en"]=> string(840) "The Korea Brain Research Institute (KBRI) and the UK Brain Disease Platform Project Group are starting joint research to develop strategies to overcome brain diseases throughout the life cycle based on clinical big data. The Brain Research Institute is working with the UK Brain Disease Platform UK (Dementia Platform UK). It was announced on the 8th that a joint research center with DPUK (hereinafter referred to as DPUK) will be opened and an international symposium will be held. DPUK is a brain disease big data and translational research platform business unit established based on the UK Biobank, with 29 partner organizations including major university hospitals such as the University of Oxford, the University of Cambridge, and the University of Edinburgh, as well as large pharmaceutical companies such as GSK and AstraZeneca. by" ["url"]=> string(59) "https://www.idaegu.co.kr/news/articleView.html?idxno=460339" ["image_url"]=> NULL ["source"]=> string(12) "idaegu.co.kr" ["publication_date"]=> string(10) "2024-05-09" ["categories"]=> array(2) { [0]=> string(5) "R & D" [1]=> string(17) "Academic Research" } } [1]=> array(7) { ["title_en"]=> string(69) "Scientists harness food by-products to fight antimicrobial resistance" ["snippet_en"]=> string(292) "Scientists are embarking on a £1.1 million project aimed at revolutionising drug production by using food by-products to develop new antimicrobial drugs.Led by the University of Strathclyde in collaboration with the University of Surrey and GSK, the research endeavours to make antimicrobial" ["url"]=> string(108) "https://www.wionews.com/science/scientists-harness-food-by-products-to-fight-antimicrobial-resistance-701123" ["image_url"]=> string(78) "https://images.businessradar.com/articles/2181e756-9b70-44f2-a0c2-27e8a8cfe02a" ["source"]=> string(11) "wionews.com" ["publication_date"]=> string(10) "2024-03-17" ["categories"]=> array(3) { [0]=> string(13) "Collaboration" [1]=> string(5) "R & D" [2]=> string(17) "Academic Research" } } [2]=> array(7) { ["title_en"]=> string(62) "“‘Low molecule collagen peptide’ promotes hair growth”" ["snippet_en"]=> string(620) "Research results have shown that 'Low Molecular Weight Collagen Peptide (LMWCP)', which is widely used to improve skin and joint health, is also effective in promoting hair growth. A research team led by Professor Beomjun Kim of the Department of Dermatology at Chung-Ang University Hospital (Director Jeongtaek Kwon) ( Dr. Kim Yu-jin and Dr. Lee Jeong-ok from the Department of Dermatology at Chung-Ang University recently published a research paper proving the hair growth promoting effect of low molecular weight collagen peptide (Low Molecular Weight Collagen Peptide (LMWCP) Promotes Hair Growth by Activating the W" ["url"]=> string(62) "http://www.docdocdoc.co.kr/news/articleView.html?idxno=3015236" ["image_url"]=> string(78) "https://images.businessradar.com/articles/56e86087-9b26-4777-b1b4-ba31222a61f0" ["source"]=> string(15) "docdocdoc.co.kr" ["publication_date"]=> string(10) "2024-03-11" ["categories"]=> array(2) { [0]=> string(18) "Ecological Impacts" [1]=> string(17) "Academic Research" } } [3]=> array(7) { ["title_en"]=> string(92) "The GSK chair of vaccines and global health at the University of Zaragoza begins its journey" ["snippet_en"]=> string(173) "The presentation event took place this Wednesday in the Paraninfo and includes experts such as Inmaculada Cuesta, secretary of the National Nursing and Vaccines Association." ["url"]=> string(116) "https://www.heraldo.es/noticias/aragon/2023/11/16/catedra-gsk-vacunas-salud-global-universidad-zaragoza-1691482.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3dc4fb74-8d1a-494e-8630-d99233ee7445" ["source"]=> string(10) "heraldo.es" ["publication_date"]=> string(10) "2023-11-16" ["categories"]=> array(3) { [0]=> string(24) "Access and affordability" [1]=> string(5) "Event" [2]=> string(17) "Academic Research" } } [4]=> array(7) { ["title_en"]=> string(44) "DEUTSCHE BANK RESEARCH upgrades GSK to 'Buy'" ["snippet_en"]=> string(259) "09/12/2023 - Deutsche Bank Research has kept GSK at 'Buy' with a price target of 1,700 pence. Since its upgrade in March, the pharmaceutical company's shares have had a difficult time and some of its expectations at the time have not been fulfilled, wrote ..." ["url"]=> string(88) "https://www.wallstreet-online.de/nachricht/17325834-deutsche-bank-research-stuft-gsk-buy" ["image_url"]=> string(78) "https://images.businessradar.com/articles/df4a7b5f-64a9-4e22-a557-aa66e8eefe22" ["source"]=> string(20) "wallstreet-online.de" ["publication_date"]=> string(10) "2023-09-12" ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(17) "Academic Research" } } [5]=> array(7) { ["title_en"]=> string(46) "GSK Uses Apple ResearchKit In Rheumatoid Study" ["snippet_en"]=> string(277) "

As the chief medical officer at GSK, Murray Stewart spends most of his time focused on patients. A recent PARADE (Patient Rheumatoid Arthritis Data from the Real World) study, launched last year, was the first time GSK attempted to use Apple ResearchKit in a clinical study." ["url"]=> string(86) "https://www.clinicalleader.com/doc/gsk-uses-apple-researchkit-in-rheumatoid-study-0001" ["image_url"]=> string(78) "https://images.businessradar.com/articles/92b9f259-2764-41b6-ae2e-736b6ce26246" ["source"]=> string(18) "clinicalleader.com" ["publication_date"]=> NULL ["categories"]=> array(2) { [0]=> string(5) "R & D" [1]=> string(17) "Academic Research" } } [6]=> array(7) { ["title_en"]=> string(64) "GSK’s ViiV, Exavir Settle Suit on HIV-Drug Compounds Licensing" ["snippet_en"]=> string(273) "ViiV Healthcare and Exavir Therapeutics ended a lawsuit over allegations that Exavir’s patent-licensing agreement with the University of Nebraska on long-acting HIV therapy compounds interfered with the GlaxoSmithKline unit’s research collaboration with the university." ["url"]=> string(97) "https://news.bloomberglaw.com/ip-law/gsks-viiv-exavir-settle-suit-on-hiv-drug-compounds-licensing" ["image_url"]=> string(78) "https://images.businessradar.com/articles/0c046181-9559-4fd5-9441-3c9595fd972a" ["source"]=> string(16) "bloomberglaw.com" ["publication_date"]=> NULL ["categories"]=> array(2) { [0]=> string(17) "Academic Research" [1]=> string(5) "Legal" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(40) } [1]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(34) } [2]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(28) } [3]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(28) } [4]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(23) } [5]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(22) } [6]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(20) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(20) } [8]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(19) } [9]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(19) } [11]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(17) } [12]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(15) } [13]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(12) } [14]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(12) } [15]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(11) } [16]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(11) } [17]=> array(2) { ["name"]=> string(6) "Crisis" ["count"]=> int(10) } [18]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(10) } [19]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(9) } [20]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(9) } [21]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(9) } [22]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(8) } [23]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(7) } [24]=> array(2) { ["name"]=> string(16) "Customer Welfare" ["count"]=> int(7) } [25]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(7) } [26]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(7) } [27]=> array(2) { ["name"]=> string(19) "Green & Responsible" ["count"]=> int(7) } [28]=> array(2) { ["name"]=> string(7) "Layoffs" ["count"]=> int(7) } [29]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(6) } } } 4abba-us-gsk-consumer-health-inc

Gsk Consumer Health, Inc.

Location

New Jersey

Founded

1994-02-28

Website

https://www.gsk.com

Articles

592 Articles

Category

Pharmaceutical Preparations

Description

GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company.

Articles

Finding strategies to overcome brain diseases based on big data

2024-05-09 (idaegu.co.kr)

Finding strategies to overcome brain diseases based on big data

The Korea Brain Research Institute (KBRI) and the UK Brain Disease Platform Project Group are starting joint research to develop strategies to overcome brain diseases throughout the life cycle based on clinical big data. The Brain Research Institute is working with the UK Brain Disease Platform UK (Dementia Platform UK). It was announced on the 8th that a joint research center with DPUK (hereinafter referred to as DPUK) will be opened and an international symposium will be held. DPUK is a brain disease big data and translational research platform business unit established based on the UK Biobank, with 29 partner organizations including major university hospitals such as the University of Oxford, the University of Cambridge, and the University of Edinburgh, as well as large pharmaceutical companies such as GSK and AstraZeneca. by

Read more
Scientists harness food by-products to fight antimicrobial resistance

2024-03-17 (wionews.com)

Scientists harness food by-products to fight antimicrobial resistance

Scientists are embarking on a £1.1 million project aimed at revolutionising drug production by using food by-products to develop new antimicrobial drugs.Led by the University of Strathclyde in collaboration with the University of Surrey and GSK, the research endeavours to make antimicrobial

Read more
“‘Low molecule collagen peptide’ promotes hair growth”

2024-03-11 (docdocdoc.co.kr)

“‘Low molecule collagen peptide’ promotes hair growth”

Research results have shown that 'Low Molecular Weight Collagen Peptide (LMWCP)', which is widely used to improve skin and joint health, is also effective in promoting hair growth. A research team led by Professor Beomjun Kim of the Department of Dermatology at Chung-Ang University Hospital (Director Jeongtaek Kwon) ( Dr. Kim Yu-jin and Dr. Lee Jeong-ok from the Department of Dermatology at Chung-Ang University recently published a research paper proving the hair growth promoting effect of low molecular weight collagen peptide (Low Molecular Weight Collagen Peptide (LMWCP) Promotes Hair Growth by Activating the W

Read more
The GSK chair of vaccines and global health at the University of Zaragoza begins its journey

2023-11-16 (heraldo.es)

The GSK chair of vaccines and global health at the University of Zaragoza begins its journey

The presentation event took place this Wednesday in the Paraninfo and includes experts such as Inmaculada Cuesta, secretary of the National Nursing and Vaccines Association.

Read more
DEUTSCHE BANK RESEARCH upgrades GSK to 'Buy'

2023-09-12 (wallstreet-online.de)

DEUTSCHE BANK RESEARCH upgrades GSK to 'Buy'

09/12/2023 - Deutsche Bank Research has kept GSK at 'Buy' with a price target of 1,700 pence. Since its upgrade in March, the pharmaceutical company's shares have had a difficult time and some of its expectations at the time have not been fulfilled, wrote ...

Read more
GSK Uses Apple ResearchKit In Rheumatoid Study

(clinicalleader.com)

GSK Uses Apple ResearchKit In Rheumatoid Study

<p>As the chief medical officer at GSK, Murray Stewart spends most of his time focused on patients. A recent PARADE (Patient Rheumatoid Arthritis Data from the Real World) study, launched last year, was the first time GSK attempted to use Apple ResearchKit in a clinical study.

Read more
GSK’s ViiV, Exavir Settle Suit on HIV-Drug Compounds Licensing

(bloomberglaw.com)

GSK’s ViiV, Exavir Settle Suit on HIV-Drug Compounds Licensing

ViiV Healthcare and Exavir Therapeutics ended a lawsuit over allegations that Exavir’s patent-licensing agreement with the University of Nebraska on long-acting HIV therapy compounds interfered with the GlaxoSmithKline unit’s research collaboration with the university.

Read more

Newsletter subscription